CFIC
AKBA icon

City Financial Investment Company’s Akebia Therapeutics AKBA Stock Holding History

City Financial Investment Company’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-188,998
Closed -$1.74M – 92
2017
Q1 		$1.74M Sell
188,998
-131,371
-41% -$1.28M 0.27% 52
2016
Q4 		$3.33M Buy
+320,369
New +$2.76M 0.61% 34

Other funds holding AKBA

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

City Financial Investment Company's AKBA Position: Q2 2017 in Review

City Financial Investment Company sold out of Akebia Therapeutics (AKBA) in Q2 2017, closing a stake of 188,998 shares — an estimated $1.74M sold.

City Financial Investment Company first reported a position in AKBA in Q4 2016 and held it in 2 quarters. The position peaked at $3.33M in Q4 2016. 119 funds tracked by Wall St. Rank hold AKBA as of Q2 2017.

  • City Financial Investment Company reported no remaining Akebia Therapeutics position as of Q2 2017 after selling out during the quarter.
  • City Financial Investment Company sold 188,998 Akebia Therapeutics shares in Q2 2017, an estimated $1.74M.
  • City Financial Investment Company first reported a position in Akebia Therapeutics in Q4 2016 and held it in 2 quarters.
  • City Financial Investment Company's Akebia Therapeutics position peaked at $3.33M in Q4 2016.
  • 119 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2017.

Based on City Financial Investment Company's 13F filing for Q2 2017, filed 14 Aug 2017.